Hakiko hewani

Habari inayoendelea · ripoti 1

The ChAdOx1 BDBV Phase I vaccine trial

Ilirushwa kwa mara ya kwanza Ilirushwa hivi punde

InaendeleaUkaguzi ujao : Further enrollment and dosing, safety monitoring, and reported study results.

Hali ilivyo

The Phase I safety study began with the first volunteer receiving a dose of ChAdOx1 BDBV in England on July 24, 2026. The study plans to enroll 50 healthy adults; enrollment, safety monitoring and results remain open, and the report gives no date for a next step.

Ufuatiliaji wa habariSiku ya 1

1 ripoti9 vyombo vya habari11 vyanzo1 video

  • Bado hakuna matukio yenye tarehe
    1. Sasisho 1First Bundibugyo Ebola Vaccine Enters Human Arm as Outbreak Toll Tops 1,000

    Habari hadi sasa

    1. Sasisho 1

      First Bundibugyo Ebola Vaccine Enters Human Arm as Outbreak Toll Tops 1,000

      Oxford gave the first Bundibugyo Ebola vaccine dose on 24 July as Central Africa's death toll passed 1,000 — with the exact count still disputed.

      Bado haijajibiwa baada ya ripoti hii

      • No verified final case and death counts, volunteer identity, or verbatim leadership quotes in provided sources.
      • No confirmed WHO emergency declaration wording or results date in provided sources.

    Historia

    1. Ilifunguliwaripoti 1

    Wanaohusika

    Watu

    • Richard HatchettAmerican epidemiologistRipoti 1

    Maeneo

    • Democratic Republic of the CongoDemocratic Republic of the CongoRipoti 1
    • OxfordOxford, UKRipoti 1
    • UgandaUgandaRipoti 1

    Kila chombo cha habari tulichosoma kuhusu habari hii

    11 vyanzo9 vyombo vya habari1 video1 nakala ya shirika la habari

    Pia imeangaziwa katika

    1. 16,000 Ebola Doses Land in Congo — For the Wrong Strain